The Enterprise Value as of December 2025 (TTM) for HBM Holdings Limited (HBMHF) is 1.18B

According to HBM Holdings Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 1.18B. This represents a change of 486.97% compared to the average of 200.98M of the last 4 quarters.

HBM Holdings Limited (HBMHF) Historical Enterprise Value (quarterly & annually)

How has HBMHF Enterprise Value performed in the past?

The mean historical Enterprise Value of HBM Holdings Limited over the last ten years is 354.92M. The current 1.18B Enterprise Value has changed 33.14% with respect to the historical average. Over the past ten years (40 quarters), HBMHF's Enterprise Value was at its highest in in the December 2018 quarter at 1.02B. The Enterprise Value was at its lowest in in the December 2020 quarter at -39684489.04.

HBM Holdings Limited (HBMHF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of HBM Holdings Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

HBM Holdings Limited (HBMHF) Average Enterprise Value

How has HBMHF Enterprise Value performed in the past?

The current Enterprise Value of HBM Holdings Limited (HBMHF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

HBM Holdings Limited (HBMHF) Enterprise Value vs. Peers

How is HBMHF’s Enterprise Value compared to its peers?

HBM Holdings Limited’s Enterprise Value is greater than Anebulo Pharmaceuticals, Inc. (83.32M), greater than Rezolute, Inc. (917.77M), greater than HCW Biologics Inc. (10.27M), greater than Eliem Therapeutics, Inc. (95.58M), greater than Molecular Partners AG (45.15M), greater than TRACON Pharmaceuticals, Inc. (-7486275.00), greater than XOMA Royalty Corp. (439.75M), greater than Sio Gene Therapies Inc. (-61213000.00), greater than Vincerx Pharma, Inc. (-4374189.00), greater than Virpax Pharmaceuticals, Inc. (-1486964.00), greater than Acurx Pharmaceuticals, Inc. (-5901444774.00), greater than MediciNova, Inc. (43.29M), greater than NextCure, Inc. (34.10M), greater than Entera Bio Ltd. (89.87M), greater than Day One Biopharmaceuticals, Inc. (812.34M), greater than Acumen Pharmaceuticals, Inc. (75.49M), greater than X4 Pharmaceuticals, Inc. (6.26M), greater than Inozyme Pharma, Inc. (279.36M), greater than VectivBio Holding AG (848.58M), greater than Bio-Path Holdings, Inc. (1.09M), greater than Endonovo Therapeutics, Inc. (6.93M), greater than Cingulate Inc. (-4702438059.00), greater than Purple Biotech Ltd. (-2462744.78), less than Soleno Therapeutics, Inc. (2.55B),

Build a custom stock screener for HBM Holdings Limited (HBMHF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HBM Holdings Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

HBM Holdings Limited (HBMHF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like HBM Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.